News
FSNUF
28.00
NaN%
--
March's Dividend Portfolio Update Sets New All-Time Record - 100 Holdings, 21 Buys
March's Dividend Portfolio Update Sets New All-Time Record - 100 Holdings, 21 Buys. Global stock indices continued an upward trend in March, with both U.S. Stocks rising by 3%. Nvidia unveiled its groundbreaking Blackwell chip at GTC 2024. The S&P 500 recorded its longest positive monthly streak since 2021.
Seeking Alpha · 1d ago
Weekly Report: what happened at FSNUF last week (0415-0419)?
Weekly Report · 4d ago
CVS favors Humira copycats hurting AbbVie’s market share: Evercore
Seeking Alpha · 04/17 13:26
Weekly Report: what happened at FSNUF last week (0408-0412)?
Weekly Report · 04/15 12:00
AbbVie keeps Humira market share near 100% despite biosimilars: report
Healthcare AbbVie keeps Humira market share near 100% despite biosimilars: report. Humira is the world's bestselling drug for the 10th year in a row. Amgen launched the first biosimilar version of the arthritis drug in the U.S. Last year.
Seeking Alpha · 04/13 14:52
European losers of higher financing costs - JPMorgan
J.P.Morgan analysts published a list of European companies that would suffer due to higher financing costs. According to a Global Markets Strategy report, if bond yields move further up, the market will weaken like it did last summer. The report published a basket of highly leveraged companies that could be the European losers.
Seeking Alpha · 04/08 13:41
Weekly Report: what happened at FSNUF last week (0401-0405)?
Weekly Report · 04/08 12:06
Weekly Report: what happened at FSNUF last week (0325-0329)?
Weekly Report · 04/01 12:03
Weekly Report: what happened at FSNUF last week (0318-0322)?
Weekly Report · 03/25 12:06
Becton, Dickinson boosts syringe production amid FDA concerns on supplies
Healthcare Becton, Dickinson boosts syringe production amid FDA concerns on supplies. FDA warned about quality issues linked to plastic syringes made in China. The company has increased the U.S. Production of syringe in its Nebraska and Connecticut plants. BD says the company has capacity to fulfill additional customer demand.
Seeking Alpha · 03/21 14:22
Weekly Report: what happened at FSNUF last week (0311-0315)?
Weekly Report · 03/18 12:04
February's Dividend Portfolio Update Sets New Record - 100 Holdings, 19 Strategic Buys
February's Dividend Portfolio Update Sets New Record - 100 Holdings, 19 Strategic Buys. US stocks climbed higher in February with the DJIA adding 0.4% and the S&P 500 closing in on the 5,000-point mark. Interest rates were kept steady in February.
Seeking Alpha · 03/13 12:10
Weekly Report: what happened at FSNUF last week (0304-0308)?
Weekly Report · 03/11 12:00
Novo Nordisk slips, dialysis stocks gain after kidney disease data for Ozempic
Novo Nordisk's weight loss drug semaglutide against kidney disease fails to impress investors. The Danish drugmaker's ADRs lost 2% in the premarket on Tuesday. Dialysis stocks traded sharply higher after dialysis company DaVita reported better-than-expected results.
Seeking Alpha · 03/05 12:30
Weekly Report: what happened at FSNUF last week (0226-0301)?
Weekly Report · 03/04 12:03
Fresenius SE: Hoping For The Turnaround In 2024
Seeking Alpha · 02/28 10:52
Weekly Report: what happened at FSNUF last week (0219-0223)?
Weekly Report · 02/26 12:22
Weekly Report: what happened at FSNUF last week (0212-0216)?
Weekly Report · 02/19 12:24
Tweedy, Browne Fund Q4 2023 Commentary
Tweedy, Browne Fund Q4 2023 Commentary: Global equity markets gained considerable momentum on the upside in Q4 2024. The funds' returns in the 4th quarter of 2023 trailed their benchmark indices. The fund's industrial and chemical holdings continued to lead the way.
Seeking Alpha · 02/15 02:40
My Dividend Stock Portfolio: New January Dividend Record - 98 Holdings With 23 Buys
My Dividend Stock Portfolio: New January Dividends Record - 98 Holdings With 23 Buys in January 2024. Markets continued to go higher in early 2024 with the Dow adding 0.4% and the S&P 500 flat in January. Net investments reached around $1,800 in January, primarily targeting high-yielding BDCs.
Seeking Alpha · 02/14 13:15
More
Webull provides a variety of real-time FSNUF stock news. You can receive the latest news about Fresenius through multiple platforms. This information may help you make smarter investment decisions.
About FSNUF
Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.